Polymorphisms and gene expression of Notch4 in pulmonary tuberculosis.

Weijun Fang, Hua Liu, Lianhua Qin, Jie Wang, Xiaochen Huang, Sha Pan, Ruijuan Zheng
Author Information
  1. Weijun Fang: School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China.
  2. Hua Liu: School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China.
  3. Lianhua Qin: Shanghai Key Lab of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  4. Jie Wang: Shanghai Key Lab of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  5. Xiaochen Huang: Shanghai Key Lab of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  6. Sha Pan: School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China.
  7. Ruijuan Zheng: School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China.

Abstract

Background: Tuberculosis (TB) is a serious public health problem to human health, but the pathogenesis of TB remains elusive.
Methods: To identify novel candidate genes associated with TB susceptibility, we performed a population-based case control study to genotype 41SNPs spanning 21 genes in 435 pulmonary TB patients and 375 health donors from China.
Results: We found Notch4 gene rs206018 and rs422951 polymorphisms were associated with susceptibility to pulmonary tuberculosis. The association was validated in another independent cohort including 790 TB patients and 1,190 healthy controls. Moreover, we identified that the rs206018 C allele was associated with higher level of Notch4 in PBMCs from pulmonary TB patients. Furthermore, Notch4 expression increased in TB patients and higher Notch4 expression correlated with the severer pulmonary TB. Finally, we explored the origin and signaling pathways involved in the regulation of Notch4 expression in response to Mycobacterium tuberculosis (Mtb) infection. We determine that Mtb induced Notch4 and its ligand Jagged1expression in macrophages, and Notch4 through TLR2/P38 signaling pathway and Jagged1 through TLR2/ERK signaling pathway.
Conclusion: Our work further strengthens that Notch4 underlay an increased risk of TB in humans and is involved in the occurrence and development of TB, which could serve as a novel target for the host-targeted therapy of TB.

Keywords

References

  1. Lancet Infect Dis. 2020 Mar;20(3):e28-e37 [PMID: 32014117]
  2. Tuberculosis (Edinb). 2020 Sep;124:101980 [PMID: 32801053]
  3. Genes Immun. 2011 Oct;12(7):523-30 [PMID: 21654846]
  4. Nat Genet. 2015 May;47(5):523-527 [PMID: 25774636]
  5. J Cancer. 2018 Jun 12;9(13):2374-2379 [PMID: 30026833]
  6. Nat Genet. 2012 Feb 05;44(3):257-9 [PMID: 22306650]
  7. Mediators Inflamm. 2019 Jan 9;2019:1349784 [PMID: 30728747]
  8. J Infect Dis. 2018 Jun 20;218(2):312-323 [PMID: 29228365]
  9. Nat Genet. 2001 Jun;28(2):126-8 [PMID: 11381257]
  10. Immunol Lett. 2013 Feb;150(1-2):130-3 [PMID: 23318300]
  11. J Biomed Sci. 2011 Aug 15;18:56 [PMID: 21843347]
  12. BMC Musculoskelet Disord. 2016 Nov 9;17(1):462 [PMID: 27829420]
  13. Genes Dev. 1992 Mar;6(3):345-55 [PMID: 1372276]
  14. J Neurosurg. 2017 May;126(5):1552-1559 [PMID: 27231971]
  15. Cancer Res. 1996 Apr 15;56(8):1775-85 [PMID: 8620493]
  16. Mult Scler. 2013 Nov;19(13):1696-703 [PMID: 23549433]
  17. Hepatology. 2015 Jul;62(1):118-28 [PMID: 25802187]
  18. Cell. 2010 Mar 5;140(5):731-43 [PMID: 20211141]
  19. J Neuroimmunol. 2012 Sep 15;250(1-2):66-70 [PMID: 22732452]
  20. Tuberculosis (Edinb). 2015 Jul;95(4):497-504 [PMID: 25937126]
  21. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1491-5 [PMID: 19703508]
  22. Cancer Med. 2017 Jul;6(7):1587-1600 [PMID: 28568708]
  23. Cell Mol Immunol. 2020 Sep;17(9):901-913 [PMID: 32728204]
  24. Int J Mol Sci. 2019 Jan 15;20(2): [PMID: 30650615]
  25. Nat Commun. 2018 Oct 4;9(1):4072 [PMID: 30287856]
  26. J Biol Chem. 2012 Feb 24;287(9):6208-17 [PMID: 22205705]
  27. Immunol Rev. 2021 May;301(1):62-83 [PMID: 33565103]
  28. Front Cell Infect Microbiol. 2018 Jul 10;8:241 [PMID: 30042932]
  29. Infect Genet Evol. 2020 Mar;78:104145 [PMID: 31838262]
  30. Oncol Lett. 2018 Jun;15(6):8749-8755 [PMID: 29805613]
  31. Infect Immun. 2003 Aug;71(8):4238-49 [PMID: 12874299]
  32. Genome Res. 2004 May;14(5):908-16 [PMID: 15078859]

MeSH Term

Humans
Toll-Like Receptor 2
Case-Control Studies
Genetic Predisposition to Disease
Polymorphism, Single Nucleotide
Tuberculosis, Pulmonary
Tuberculosis
Gene Expression
Receptor, Notch4

Chemicals

Toll-Like Receptor 2
NOTCH4 protein, human
Receptor, Notch4

Word Cloud

Created with Highcharts 10.0.0TBNotch4pulmonaryexpressionpatientstuberculosishealthassociatedsignalingnovelgenessusceptibilitygeners206018higherincreasedinvolvedMycobacteriumMtbpathwayBackground:TuberculosisseriouspublicproblemhumanpathogenesisremainselusiveMethods:identifycandidateperformedpopulation-basedcasecontrolstudygenotype41SNPsspanning21435375donorsChinaResults:foundrs422951polymorphismsassociationvalidatedanotherindependentcohortincluding7901190healthycontrolsMoreoveridentifiedCallelelevelPBMCsFurthermorecorrelatedsevererFinallyexploredoriginpathwaysregulationresponseinfectiondetermineinducedligandJagged1expressionmacrophagesTLR2/P38Jagged1TLR2/ERKConclusion:workstrengthensunderlayriskhumansoccurrencedevelopmentservetargethost-targetedtherapyPolymorphismsNOTCH4clinicalsignificancepolymorphism

Similar Articles

Cited By